Dyslipidaemia is the most common risk factor for atherosclerosis in Poland, affecting roughly 18 million adults; this study specifically aimed to evaluate the effectiveness of statin therapy among high-risk patients.
The 3ST-POL study included nearly 50,000 Polish outpatients aged 40 to 85 who had been on statin therapy for at least three months, with 72% classified as high-risk; the majority of patients were treated by general practitioners.
Results showed that only a small percentage of patients reached the recommended cholesterol levels, indicating that the current approach to managing dyslipidaemia in this population needs improvement.